Comparison timestamp: 2025-05-05 14:26:21 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/tb-surveillance-report-2023/tables/table-26.html
Live cdc.gov URL ↗: https://www.cdc.gov/tb-surveillance-report-2023/tables/table-26.html
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/tb-surveillance-report-2023/tables/table-26.html
Live cdc.gov URL ↗: https://www.cdc.gov/tb-surveillance-report-2023/tables/table-26.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/tb-surveillance-report-2023/tables/table-26.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to site content Skip directly to searchAn official website of the United States governmentHere's how you knowOfficial websites use .govA .gov website belongs to an official government organization in the United States.Secure .gov websites use HTTPSA lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.Reported Tuberculosis in the United States, 2023Explore TopicsSearchSearchClear InputFor Everyone* Data Tables* About the Data* Executive Commentary* Communication Resources* View allView Allsearch close searchsearchReported Tuberculosis in the United States, 2023 Menu CloseReported Tuberculosis in the United States, 2023 MenusearchFor Everyone* Data Tables* About the Data* Executive Commentary* Communication Resources* View All HomeView All Reported Tuberculosis in the United States, 2023Data Tables About the Data Executive Commentary Communication Resources View AllOctober 31, 2024TB Characteristics in wgMLSType Clusters: 2021–2023Characteristics of Tuberculosis Cases in wgMLSType Clusters by Alert Levels Based on Log-Likelihood Ratio (LLR): United States, 2021–2023What to knowThis table describes the characteristics of tuberculosis (TB) disease cases in whole genome sequencing (wgMLSType) clusters by alert levels based on log-likelihood ratio in the United States from 2021 to 2023.Characteristics of Tuberculosis Cases in wgMLSType Clusters1 by Alert Levels Based on Log-Likelihood Ratio (LLR):2 United States, 2021–2023CDC describes cases of TB disease in whole genome sequencing clusters by alert level, 2021-2023.Characteristics Unique Clustered Alert levels for clustered cases3Non-alerted Medium High(LLR <4) (LLR 4 – <10) (LLR ≥10)No. (%) No. (%) No. (%) No. (%) No. (%)Total 16,061 (82.6) 3,384 (17.4) 1,253 (37.0) 1,325 (39.2) 806 (23.8)Origin of birth4U.S.-born 2,874 (62.0) 1,758 (38.0) 507 (28.8) 621 (35.3) 630 (35.8)Non-U.S.–born 13,125 (89.1) 1,613 (10.9) 739 (45.8) 699 (43.3) 175 (10.8)Unknown or missing 62 (82.7) 13 (17.3) 7 (53.8) 5 (38.5) 1 (7.7)Race and ethnicity5Hispanic or Latino 5,132 (77.0) 1,531 (23.0) 727 (47.5) 560 (36.6) 244 (15.9)American Indian or Alaska Native 75 (33.8) 147 (66.2) 3 (2.0) 30 (20.4) 114 (77.6)Asian 6,316 (94.8) 346 (5.2) 137 (39.6) 189 (54.6) 20 (5.8)Black or African American 2,399 (74.9) 806 (25.1) 208 (25.8) 293 (36.4) 305 (37.8)Native Hawaiian or Other Pacific Islander 115 (43.7) 148 (56.3) 40 (27.0) 88 (59.5) 20 (13.5)White 1,531 (82.8) 318 (17.2) 118 (37.1) 129 (40.6) 71 (22.3)Multiple race 324 (84.8) 58 (15.2) 12 (20.7) 24 (41.4) 22 (37.9)Unknown or missing 62 (77.5) 18 (22.5) 3 (16.7) 5 (27.8) 10 (55.6)Age group (years)60–4 55 (32.7) 113 (67.3) 26 (23.0) 58 (51.3) 29 (25.7)5–14 135 (60.3) 89 (39.7) 19 (21.3) 43 (48.3) 27 (30.3)15–24 1,481 (75.8) 472 (24.2) 200 (42.4) 181 (38.3) 91 (19.3)25–44 4,652 (79.7) 1,185 (20.3) 442 (37.3) 466 (39.3) 277 (23.4)45–64 4,581 (80.6) 1,102 (19.4) 390 (35.4) 414 (37.6) 298 (27.0)≥65 5,156 (92.4) 423 (7.6) 176 (41.6) 163 (38.5) 84 (19.9)Disease sitePulmonary only 11,502 (81.1) 2,686 (18.9) 976 (36.3) 1,066 (39.7) 644 (24.0)Extrapulmonary 2,458 (89.5) 287 (10.5) 119 (41.5) 97 (33.8) 71 (24.7)Both 2,055 (83.5) 407 (16.5) 158 (38.8) 158 (38.8) 91 (22.4)Unknown 46 (92.0) 4 (8.0) 0 (0.0) 4 (100.0) 0 (0.0)Sputum smearPositive 7,967 (80.1) 1,979 (19.9) 719 (36.3) 786 (39.7) 474 (24.0)Negative 6,448 (85.3) 1,111 (14.7) 439 (39.5) 410 (36.9) 262 (23.6)Not done 1,449 (84.6) 263 (15.4) 83 (31.6) 113 (43.0) 67 (25.5)Unknown or missing 197 (86.4) 31 (13.6) 12 (38.7) 16 (51.6) 3 (9.7)Cavitary disease7Yes 167 (77.7) 48 (22.3) 18 (37.5) 19 (39.6) 11 (22.9)No 1,442 (83.2) 292 (16.8) 124 (42.5) 104 (35.6) 64 (21.9)Unknown or missing 9 (90.0) 1 (10.0) 0 (0.0) 1 (100.0) 0 (0.0)Homeless within past yearYes 688 (64.5) 378 (35.5) 176 (46.6) 104 (27.5) 98 (25.9)No 15,195 (83.6) 2,970 (16.4) 1,065 (35.9) 1,206 (40.6) 699 (23.5)Unknown or missing 178 (83.2) 36 (16.8) 12 (33.3) 15 (41.7) 9 (25.0)Excess alcohol use within past yearYes 1,201 (70.2) 511 (29.8) 159 (31.1) 189 (37.0) 163 (31.9)No 14,572 (83.8) 2,808 (16.2) 1,062 (37.8) 1,113 (39.6) 633 (22.5)Unknown or missing 288 (81.6) 65 (18.4) 32 (49.2) 23 (35.4) 10 (15.4)Injecting drug use within past yearYes 124 (61.1) 79 (38.9) 24 (30.4) 26 (32.9) 29 (36.7)No 15,619 (82.9) 3,225 (17.1) 1,190 (36.9) 1,277 (39.6) 758 (23.5)Unknown or missing 318 (79.9) 80 (20.1) 39 (48.8) 22 (27.5) 19 (23.8)Noninjecting drug use within past yearYes 812 (55.0) 665 (45.0) 237 (35.6) 190 (28.6) 238 (35.8)No 14,936 (84.9) 2,654 (15.1) 987 (37.2) 1,115 (42.0) 552 (20.8)Unknown or missing 313 (82.8) 65 (17.2) 29 (44.6) 20 (30.8) 16 (24.6)Resident of a correctional facility at time of diagnosisYes 371 (67.9) 175 (32.1) 64 (36.6) 44 (25.1) 67 (38.3)No 15,600 (83.0) 3,189 (17.0) 1,180 (37.0) 1,271 (39.9) 738 (23.1)Unknown or missing 90 (81.8) 20 (18.2) 9 (45.0) 10 (50.0) 1 (5.0)HIV statusPositive 634 (75.7) 204 (24.3) 82 (40.2) 67 (32.8) 55 (27.0)Negative 13,702 (82.2) 2,962 (17.8) 1,098 (37.1) 1,150 (38.8) 714 (24.1)Refused 257 (91.8) 23 (8.2) 9 (39.1) 12 (52.2) 2 (8.7)Not offered 517 (87.0) 77 (13.0) 33 (42.9) 29 (37.7) 15 (19.5)Unknown, missing, or indeterminate 951 (89.0) 118 (11.0) 31 (26.3) 67 (56.8) 20 (16.9)Multidrug-resistant TB8Yes 234 (89.0) 29 (11.0) 5 (17.2) 18 (62.1) 6 (20.7)No 15,141 (82.4) 3,236 (17.6) 1,213 (37.5) 1,254 (38.8) 769 (23.8)Unknown or missing 686 (85.2) 119 (14.8) 35 (29.4) 53 (44.5) 31 (26.1)1wgMLSType clusters have two or more cases with matching wgMLSType within a county during the specified 3-year time period.2Alert levels are based on a log-likelihood ratio, which calculates the geographical concentration of a genotype in a county compared to the rest of the country during a 3-year period.3There were 3,384 cases in 1,110 clusters: 806 cases were in 82 (7.4%) high alert clusters; 1,325 cases were in 496 (44.7%) medium alert clusters, and 1,253 cases were in 532 (47.9%) non-alert clusters.4Persons born in the United States, certain U.S. territories, or elsewhere to at least one U.S. citizen parent are categorized as U.S.-born. All other persons are categorized as non-U.S.–born.5Persons who identified as Hispanic or Latino were categorized as "Hispanic," regardless of self-reported race. Persons who did not identify as Hispanic or Latino were categorized by self-reported race; if more than one race was reported, the person was categorized as "Multiple race." Due to “Other race” being first reported as a new race category in 2023, information for 119 persons reporting “Other race” was not included in this table.6One person with a unique wgMLSType and an unknown age was excluded.7Cavitary disease only assessed for persons with pulmonary TB and an abnormal x-ray.8Starting in 2023, information on drug resistance included results of molecular drug susceptibility testing in addition to growth-based susceptibility testing for isoniazid and rifampin. An isolate is considered resistant to isoniazid or rifampin if either the growth-based test or molecular test detects resistance.NoteData for all years are updated through July 17, 2024.ResourcesTuberculosis in the United States, 2023 Slide SetDownload the slide set of data visualizations for Reported Tuberculosis in the United States, 2023.Nov. 5, 2024DownloadDownloadExecutive CommentaryCDC describes cases of tuberculosis disease in the United States reported in 2023.Oct. 16, 2024Table Printing TipsFollow these instructions to print data tables in Reported Tuberculosis in the United States, 2023.Oct. 28, 2024Related Pages* Data Tables* TB by Pregnancy: 2023* Non-HIV Medical Risk Factors for TB by Origin of Birth and Race/Ethnicity: 2023* TB Clusters by Cluster Size: 2021–2023** TB by Age Group and Reporting Areas: 2023*View All Reported Tuberculosis in the United States, 2023Back to TopTB Clusters by Cluster Size: 2021–2023October 31, 2024Sources Print ShareFacebook LinkedIn Twitter SyndicateContent Source:Division of Tuberculosis Elimination; National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; Centers for Disease Control and PreventionRelated Pages* Data Tables* TB by Pregnancy: 2023* Non-HIV Medical Risk Factors for TB by Origin of Birth and Race/Ethnicity: 2023* TB Clusters by Cluster Size: 2021–2023** TB by Age Group and Reporting Areas: 2023*View All Reported Tuberculosis in the United States, 2023Back to TopReported Tuberculosis in the United States, 2023Reported Tuberculosis in the United States, 2023 describes cases of tuberculosis (TB) disease reported to CDC during 1993–2023.View All* Data Tables* About the Data* Executive Commentary* Communication ResourcesSign up for Email UpdatesContact UsContact Us* Call 800-232-4636* Contact CDCAbout CDCAbout CDC* Pressroom* Organization* Budget & Funding* Careers & JobsPolicies* Accessibility* External Links* Privacy* Web Policies* FOIA* OIG* No Fear Act* Nondiscrimination* Vulnerability Disclosure PolicyLanguagesLanguages* EspañolLanguage Assistance* Español* 繁體中文* Tiếng Việt* 한국어* Tagalog* Русский* العربية* Kreyòl Ayisyen* Français* Polski* Português* Italiano* Deutsch* 日本語* فارسی* EnglishArchive* CDC Archive* Public Health PublicationsContact UsContact Us* Call 800-232-4636* Contact CDCAbout CDC* Pressroom* Organization* Budget & Funding* Careers & Jobs* About CDCPolicies* Accessibility* External Links* Privacy* Web Policies* FOIA* OIG* No Fear Act* Nondiscrimination* Vulnerability Disclosure PolicyLanguagesLanguages* EspañolLanguage Assistance* Español* 繁體中文* Tiếng Việt* 한국어* Tagalog* Русский* العربية* Kreyòl Ayisyen* Français* Polski* Português* Italiano* Deutsch* 日本語* فارسی* EnglishArchive* CDC Archive* Public Health PublicationsHHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.